×
Merck Receivables 2010-2024 | MKKGY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Merck receivables for the quarter ending June 30, 2024 were
$5.085B
, a
1.18% decline
year-over-year.
Merck receivables for 2023 were
$4.845B
, a
0.85% increase
from 2022.
Merck receivables for 2022 were
$4.804B
, a
1.86% decline
from 2021.
Merck receivables for 2021 were
$4.896B
, a
14.56% increase
from 2020.
View More
Merck Receivables 2010-2024 | MKKGY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Merck receivables for 2023 were
$4.845B
, a
0.85% increase
from 2022.
Merck receivables for 2022 were
$4.804B
, a
1.86% decline
from 2021.
Merck receivables for 2021 were
$4.896B
, a
14.56% increase
from 2020.
Related Stocks
Company Name
Market
Cap
New York Community Bancorp (FLG)
$4.3B
Acasti Pharma (GRCE)
$33M